Previously, AMPK was viewed as a tumor suppressor, based on its ability to inhibit anabolic processes and mediate the tumor suppressive effects of LKB1, such as promoting cell growth through the inactivation of mTORC1 (22–24). This evidence concerns the gene PRKAA1 and neoplasm.